Exact Mass: 245.1375

Exact Mass Matches: 245.1375

Found 160 metabolites which its exact mass value is equals to given mass value 245.1375, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tropacocain

3beta-Benzoyloxytropane

C15H19NO2 (245.1416)


   

Benzoyltropein

3alpha-Benzoyloxytropane

C15H19NO2 (245.1416)


   

Glutaminylvaline

(2S)-2-{[(2S)-2-amino-1-hydroxy-4-(C-hydroxycarbonimidoyl)butylidene]amino}-3-methylbutanoate

C10H19N3O4 (245.1375)


Glutaminylvaline is a dipeptide composed of glutamine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Asparaginylisoleucine

(2S,3S)-2-{[(2S)-2-amino-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-3-methylpentanoate

C10H19N3O4 (245.1375)


Asparaginylisoleucine is a dipeptide composed of asparagine and isoleucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Valylglutamine

(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carbamoylbutanoic acid

C10H19N3O4 (245.1375)


Valylglutamine is a dipeptide composed of valine and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Isoleucyl-Asparagine

2-[(2-Amino-1-hydroxy-3-methylpentylidene)amino]-3-(C-hydroxycarbonimidoyl)propanoate

C10H19N3O4 (245.1375)


Isoleucyl-Asparagine is a dipeptide composed of isoleucine and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Asparaginyl-Leucine

2-{[2-amino-1-hydroxy-3-(C-hydroxycarbonimidoyl)propylidene]amino}-4-methylpentanoate

C10H19N3O4 (245.1375)


Asparaginyl-Leucine is a dipeptide composed of asparagine and leucine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Leucyl-Asparagine

2-[(2-Amino-1-hydroxy-4-methylpentylidene)amino]-3-(C-hydroxycarbonimidoyl)propanoate

C10H19N3O4 (245.1375)


Leucyl-Asparagine is a dipeptide composed of leucine and asparagine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Valyl-Gamma-glutamate

2-Amino-4-[(2-amino-3-methylbutanoyl)-C-hydroxycarbonimidoyl]butanoate

C10H19N3O4 (245.1375)


Valyl-Gamma-glutamate is a dipeptide composed of valine and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

S-3-oxodecanoyl cysteamine

1-[(2-Aminoethyl)sulphanyl]decane-1,3-dione

C12H23NO2S (245.1449)


S-3-oxodecanoyl cysteamine belongs to the family of Thioesters. These are compounds containing the ester derivative of thiocarboxylic acid,with the general structure R-S-CO-R (R,R=alkyl,aryl)

   

[(1R,5R)-5-(6-Aminopurin-9-yl)cyclohex-3-en-1-yl]methanol

[(1R,5R)-5-(6-Aminopurin-9-yl)cyclohex-3-en-1-yl]methanol

C12H15N5O (245.1277)


   

N-(3-(5,6,7,8-Tetrahydro-2-naphthyl)prop-2-enyl)acetohydroxamic acid

N-hydroxy-N-[3-(5,6,7,8-tetrahydronaphthalen-2-yl)prop-2-en-1-yl]acetamide

C15H19NO2 (245.1416)


   

Bisnortilidin

Ethyl 2-amino-1-phenylcyclohex-3-ene-1-carboxylic acid

C15H19NO2 (245.1416)


   

Tasimelteon

N-{[2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanimidate

C15H19NO2 (245.1416)


   
   

6-hydroxy-1H-indole-3-carbaldehyde

1-(6-Hydroxyhexyl)-1H-3-indolecarbaldehyde

C15H19NO2 (245.1416)


   

Methyl 1-pentyl-1H-indole-3-carboxylate

Methyl 1-pentyl-1H-indole-3-carboxylate

C15H19NO2 (245.1416)


   

DL-Leucylglycylglycine

DL-Leucylglycylglycine

C10H19N3O4 (245.1375)


   

1,6-dihydro-6-imino-1,7-dimethyl-3-((E)-3-methylbuta-1,3-dienyl)-3H-purin-2(7H)-one|dioicine

1,6-dihydro-6-imino-1,7-dimethyl-3-((E)-3-methylbuta-1,3-dienyl)-3H-purin-2(7H)-one|dioicine

C12H15N5O (245.1277)


   

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]acetamide

N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]acetamide

C15H19NO2 (245.1416)


   

1-(1H-Indol-3-yl)-2-hydroxy-4-methylhexan-3-one

1-(1H-Indol-3-yl)-2-hydroxy-4-methylhexan-3-one

C15H19NO2 (245.1416)


   

3-phenylacetoxynortropane|nortropan-3-yl phenylacetate|Phenylessigsaeure-nortropinester

3-phenylacetoxynortropane|nortropan-3-yl phenylacetate|Phenylessigsaeure-nortropinester

C15H19NO2 (245.1416)


   

Sterostrein M

Sterostrein M

C15H19NO2 (245.1416)


   

divaricatine D

divaricatine D

C15H19NO2 (245.1416)


   

Laburnin-benzoat

Laburnin-benzoat

C15H19NO2 (245.1416)


   
   

SCHEMBL18613826

SCHEMBL18613826

C10H19N3O4 (245.1375)


   
   
   
   
   
   
   

Leu-Gly-Gly

Leu-Gly-Gly

C10H19N3O4 (245.1375)


A tripeptide composed of one L-leucine and two glycine residues joined in sequence. CONFIDENCE standard compound; INTERNAL_ID 164

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Asn-Ile

2-(2-amino-3-methylpentanamido)-3-carbamoylpropanoic acid

C10H19N3O4 (245.1375)


A dipeptide obtained by formal condensation of the carboxy group of L-asparagine with the amino group of L-isoleucine.

   

Asn-leu

2-(2-amino-4-methylpentanamido)-3-carbamoylpropanoic acid

C10H19N3O4 (245.1375)


   

GLN-Val

2-(2-amino-3-methylbutanamido)-4-carbamoylbutanoic acid

C10H19N3O4 (245.1375)


   

Ile-Asn

2-(2-amino-3-carbamoylpropanamido)-3-methylpentanoic acid

C10H19N3O4 (245.1375)


A dipeptide formed from L-isoleucine and L-asparagine residues.

   

Leu-asn

2-(2-amino-3-carbamoylpropanamido)-4-methylpentanoic acid

C10H19N3O4 (245.1375)


A dipeptide composed of L-leucine and L-asparagine joined by a peptide linkage.

   

Val-Gln

2-(2-amino-4-carbamoylbutanamido)-3-methylbutanoic acid

C10H19N3O4 (245.1375)


A dipeptide formed from L-valine and L-glutamine residues.

   

Val-gglu

2-[2-amino-4-(C-hydroxycarbonimidoyl)butanamido]-3-methylbutanoic acid

C10H19N3O4 (245.1375)


   

GGlu-Val

2-(2-amino-3-methylbutanamido)-4-(C-hydroxycarbonimidoyl)butanoic acid

C10H19N3O4 (245.1375)


   

1-[Cyano-(p-methoxyphenyl)methyl]cyclohexanol

1-[Cyano-(p-methoxyphenyl)methyl]cyclohexanol

C15H19NO2 (245.1416)


   

Gly-gly-ile

Glycylglycyl-l-isoleucine

C10H19N3O4 (245.1375)


A tripeptide composed of glycine, glycine and L-isoleucine residues joined in sequence.

   

Gly-gly-leu

Gly-gly-leu

C10H19N3O4 (245.1375)


A tripeptide composed of glycine, glycine and L-leucine residues joined in sequence.

   

H-D-Leu-Gly-Gly-OH

H-D-Leu-Gly-Gly-OH

C10H19N3O4 (245.1375)


   

2-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinonitrile

2-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinonitrile

C12H16BN3O2 (245.1336)


   

Methyl (2S,3S)-3-[(tert-butyldimethylsilyl)oxy]azetidine-2-carbo

Methyl (2S,3S)-3-[(tert-butyldimethylsilyl)oxy]azetidine-2-carbo

C11H23NO3Si (245.1447)


   

6-Amino-4-cyanopyridine-3-boronic acid pinacol ester

6-Amino-4-cyanopyridine-3-boronic acid pinacol ester

C12H16BN3O2 (245.1336)


   

(S)-Tert-Butyl (1,5-diamino-1,5-dioxopentan-2-yl)carbamate

(S)-Tert-Butyl (1,5-diamino-1,5-dioxopentan-2-yl)carbamate

C10H19N3O4 (245.1375)


   

3-butyl-1-ethyl-4-hydroxyquinolin-2-one

3-butyl-1-ethyl-4-hydroxyquinolin-2-one

C15H19NO2 (245.1416)


   

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine hydrochloride

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine hydrochloride

C11H21BClNO2 (245.1354)


   

5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine

5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazolo[3,4-b]pyridine

C12H16BN3O2 (245.1336)


   

3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyrimidine

3-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyrimidine

C12H16BN3O2 (245.1336)


   

1-(4-METHYLOXAZOL-5-YL)ETHANONE

1-(4-METHYLOXAZOL-5-YL)ETHANONE

C15H19NO2 (245.1416)


   

6,7-dimethylspiro[3H-chromene-2,4-piperidine]-4-one

6,7-dimethylspiro[3H-chromene-2,4-piperidine]-4-one

C15H19NO2 (245.1416)


   

GNF179 (Metabolite)

GNF179 (Metabolite)

C14H16FN3 (245.1328)


   

trans-2-(4-cyanophenyl)-5-n-butyl-1,3-dioxane

trans-2-(4-cyanophenyl)-5-n-butyl-1,3-dioxane

C15H19NO2 (245.1416)


   

Leucyl-glycyl-glycine

Leucyl-glycyl-glycine

C10H19N3O4 (245.1375)


   

9-Benzyl-6-oxa-9-azaspiro[3.6]decan-8-one

9-Benzyl-6-oxa-9-azaspiro[3.6]decan-8-one

C15H19NO2 (245.1416)


   

10-benzyl-5,8-dioxa-10-azadispiro[2.0.44.33]undecane

10-benzyl-5,8-dioxa-10-azadispiro[2.0.44.33]undecane

C15H19NO2 (245.1416)


   

ETHYL 3-BENZYL-3-AZA-BICYCLO[3.1.0]HEXANE-6-CARBOXYLATE

ETHYL 3-BENZYL-3-AZA-BICYCLO[3.1.0]HEXANE-6-CARBOXYLATE

C15H19NO2 (245.1416)


   

5-tert-butyl-1H-indole-2-carboxylic acid ethyl ester

5-tert-butyl-1H-indole-2-carboxylic acid ethyl ester

C15H19NO2 (245.1416)


   

H-Gly-Leu-Gly-OH

N-(N-Glycyl-L-leucyl)glycine

C10H19N3O4 (245.1375)


   

7-Benzyl-2-oxa-7-azaspiro[4.5]decan-1-one

7-Benzyl-2-oxa-7-azaspiro[4.5]decan-1-one

C15H19NO2 (245.1416)


   

8-Benzyl-1-oxa-8-azaspiro[4.5]decan-2-one

8-Benzyl-1-oxa-8-azaspiro[4.5]decan-2-one

C15H19NO2 (245.1416)


   

Methyl spiro[cyclohexane-1,3-indoline]-4-carboxylate

Methyl spiro[cyclohexane-1,3-indoline]-4-carboxylate

C15H19NO2 (245.1416)


   
   

trans-4-(5-Butyl-1,3-dioxane-2-yl)benzenenitril

trans-4-(5-Butyl-1,3-dioxane-2-yl)benzenenitril

C15H19NO2 (245.1416)


   

1-Benzyl-4-cyclopropyl-3-pyrrolidinecarboxylic acid

1-Benzyl-4-cyclopropyl-3-pyrrolidinecarboxylic acid

C15H19NO2 (245.1416)


   

1-(Hydroxycyclohexyl)-(4-methoxyphenyl)acetonitrile

1-(Hydroxycyclohexyl)-(4-methoxyphenyl)acetonitrile

C15H19NO2 (245.1416)


   

1H-Benzo[d][1,2,3]triazol-5-ylboronic acid pinacol ester

1H-Benzo[d][1,2,3]triazol-5-ylboronic acid pinacol ester

C12H16BN3O2 (245.1336)


   

(S,S,S)-2-Azabicyclo[3,3,0]octane-3-carboxylic acid benzylester hydrochloride

(S,S,S)-2-Azabicyclo[3,3,0]octane-3-carboxylic acid benzylester hydrochloride

C15H19NO2 (245.1416)


   

Tasimelteon

Tasimelteon

C15H19NO2 (245.1416)


N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CH - Melatonin receptor agonists C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   

1-BENZYL-1,2,3,6-TETRAHYDROISONICOTINIC ACID ETHYL ESTER

1-BENZYL-1,2,3,6-TETRAHYDROISONICOTINIC ACID ETHYL ESTER

C15H19NO2 (245.1416)


   

N,N-dimethyl-4-(4-oxocyclohexyl)benzamide

N,N-dimethyl-4-(4-oxocyclohexyl)benzamide

C15H19NO2 (245.1416)


   

[1,2,4]triazolo[1,5-a]pyridine-6-boronic acid pinacol ester

[1,2,4]triazolo[1,5-a]pyridine-6-boronic acid pinacol ester

C12H16BN3O2 (245.1336)


   

BoroGly-(+)-Pinanediol-HCl

BoroGly-(+)-Pinanediol-HCl

C11H21BClNO2 (245.1354)


   

N-(3-(5,6,7,8-Tetrahydro-2-naphthyl)prop-2-enyl)acetohydroxamic acid

N-(3-(5,6,7,8-Tetrahydro-2-naphthyl)prop-2-enyl)acetohydroxamic acid

C15H19NO2 (245.1416)


   

Glycyl-alanyl-valine

Glycyl-alanyl-valine

C10H19N3O4 (245.1375)


   

Glycine, L-alanyl-L-valyl-

Glycine, L-alanyl-L-valyl-

C10H19N3O4 (245.1375)


   
   

Asparaginyl-Leucine

Asparaginyl-Leucine

C10H19N3O4 (245.1375)


   

L-Valylglycyl-L-alanine

L-Valylglycyl-L-alanine

C10H19N3O4 (245.1375)


   

Glycine, L-isoleucylglycyl-

Glycine, L-isoleucylglycyl-

C10H19N3O4 (245.1375)


   

L-Valyl-L-alanylglycine

L-Valyl-L-alanylglycine

C10H19N3O4 (245.1375)


   

4-(ethoxycarbonyl)-3,5-dimethyl-1-phenyl-1H-pyrazol-2-ium

4-(ethoxycarbonyl)-3,5-dimethyl-1-phenyl-1H-pyrazol-2-ium

C14H17N2O2+ (245.129)


   

Asparagylisoleucine

Asparagylisoleucine

C10H19N3O4 (245.1375)


   

L-Leucyl-L-asparagine

L-Leucyl-L-asparagine

C10H19N3O4 (245.1375)


   

L-Isoleucyl-L-asparagine

L-Isoleucyl-L-asparagine

C10H19N3O4 (245.1375)


   
   
   
   
   

4-(N-Maleimido)benzyltrimethylammonium

4-(N-Maleimido)benzyltrimethylammonium

C14H17N2O2+ (245.129)


   

Acremolin B

Acremolin B

C12H15N5O (245.1277)


An imidazopurine that is 4,5-dihydro-1H-imidazo[2,1-b]purine substituted by methyl, oxo, methyl, and isopropyl groups at positions 1, 4, 5, and 7, respectively. It is a natural product isolated from the deep-sea-derived fungus Aspergillus sp. SCSIO Ind09F01.

   

Glycyl-valyl-alanine

Glycyl-valyl-alanine

C10H19N3O4 (245.1375)


   

4-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)butanoic acid

4-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)butanoic acid

C15H19NO2 (245.1416)


   

(2S)-2-hydroxy-4-methyl-1-(1-methylindol-3-yl)pentan-3-one

(2S)-2-hydroxy-4-methyl-1-(1-methylindol-3-yl)pentan-3-one

C15H19NO2 (245.1416)


   

N-(4-Phenylbutyryl)piperidin-2-one

N-(4-Phenylbutyryl)piperidin-2-one

C15H19NO2 (245.1416)


   

N-(4,4-Dideutero-4-phenylbutyryl)piperidin-2-one

N-(4,4-Dideutero-4-phenylbutyryl)piperidin-2-one

C15H19NO2 (245.1416)


   

N-(3,3-Dideutero-4-phenylbutyryl)piperidin-2-one

N-(3,3-Dideutero-4-phenylbutyryl)piperidin-2-one

C15H19NO2 (245.1416)


   

N-(2,2-Dideutero-4-phenylbutyryl)piperidin-2-one

N-(2,2-Dideutero-4-phenylbutyryl)piperidin-2-one

C15H19NO2 (245.1416)


   

N-(3,3,4,4-Tetradeutero-4-phenylbutyryl)piperidin-2-one

N-(3,3,4,4-Tetradeutero-4-phenylbutyryl)piperidin-2-one

C15H19NO2 (245.1416)


   

N-(2,2,3,3-Tetradeutero-4-phenylbutyryl)piperidin-2-one

N-(2,2,3,3-Tetradeutero-4-phenylbutyryl)piperidin-2-one

C15H19NO2 (245.1416)


   

N-(2,2,4,4-Tetradeutero-4-phenylbutyryl)piperidin-2-one

N-(2,2,4,4-Tetradeutero-4-phenylbutyryl)piperidin-2-one

C15H19NO2 (245.1416)


   

N-(2,2,3,3,4,4-Hexadeutero-4-phenylbutyryl)piperidin-2-one

N-(2,2,3,3,4,4-Hexadeutero-4-phenylbutyryl)piperidin-2-one

C15H19NO2 (245.1416)


   

3-Hexanoyl-5-phenyl-2-isoxazoline

3-Hexanoyl-5-phenyl-2-isoxazoline

C15H19NO2 (245.1416)


   

1-(2-Phenylbutyryl)piperidin-2-one

1-(2-Phenylbutyryl)piperidin-2-one

C15H19NO2 (245.1416)


   

1-(3-Phenylbutyryl)piperidin-2-one

1-(3-Phenylbutyryl)piperidin-2-one

C15H19NO2 (245.1416)


   

Methyl 5-ethyl-3-methyl-2-phenyl-1-pyrroline-4-carboxylate (3,4-trans-4,5-cis)

Methyl 5-ethyl-3-methyl-2-phenyl-1-pyrroline-4-carboxylate (3,4-trans-4,5-cis)

C15H19NO2 (245.1416)


   

Methyl trans-5-ethyl-ref.-4-methyl-2-phenyl-1-pyrroline-4-carboxylate

Methyl trans-5-ethyl-ref.-4-methyl-2-phenyl-1-pyrroline-4-carboxylate

C15H19NO2 (245.1416)


   

Leucylasparagine

Leucylasparagine

C10H19N3O4 (245.1375)


   

S-3-oxodecanoyl cysteamine

S-3-oxodecanoyl cysteamine

C12H23NO2S (245.1449)


   

Glutaminylvaline

Glutaminylvaline

C10H19N3O4 (245.1375)


   

Valyl-Gamma-glutamate

Valyl-Gamma-glutamate

C10H19N3O4 (245.1375)


   

Gly-Gly-Ile zwitterion

Gly-Gly-Ile zwitterion

C10H19N3O4 (245.1375)


A tripeptide zwitterion resulting from the transfer of a proton from the carboxy group to the amino group of Gly-Gly-Ile. Major microspecies at pH 7.3.

   
   
   
   
   
   
   
   
   

1-(6-hydroxyhexyl)indole-3-carbaldehyde

1-(6-hydroxyhexyl)indole-3-carbaldehyde

C15H19NO2 (245.1416)


   

n-[2-(2,2-dimethylchromen-6-yl)ethyl]ethanimidic acid

n-[2-(2,2-dimethylchromen-6-yl)ethyl]ethanimidic acid

C15H19NO2 (245.1416)


   

7-isopropyl-1,5-dimethylimidazo[2,1-b]purin-4-one

7-isopropyl-1,5-dimethylimidazo[2,1-b]purin-4-one

C12H15N5O (245.1277)


   

(2r)-2-hydroxy-1-(1h-indol-3-yl)-4-methylhexan-3-one

(2r)-2-hydroxy-1-(1h-indol-3-yl)-4-methylhexan-3-one

C15H19NO2 (245.1416)


   

6-imino-1,7-dimethyl-3-(3-methylbuta-1,3-dien-1-yl)purin-2-one

6-imino-1,7-dimethyl-3-(3-methylbuta-1,3-dien-1-yl)purin-2-one

C12H15N5O (245.1277)


   

(1r,3r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

(1r,3r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

C15H19NO2 (245.1416)


   

2-hydroxy-1-(1h-indol-3-yl)-4-methylhexan-3-one

2-hydroxy-1-(1h-indol-3-yl)-4-methylhexan-3-one

C15H19NO2 (245.1416)


   

6-imino-1,7-dimethyl-3-[(1e)-3-methylbuta-1,3-dien-1-yl]purin-2-one

6-imino-1,7-dimethyl-3-[(1e)-3-methylbuta-1,3-dien-1-yl]purin-2-one

C12H15N5O (245.1277)


   

(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

C15H19NO2 (245.1416)


   

(2e)-2-methyl-3-[4-(4-methylidenecyclohexyl)furan-2-yl]prop-2-enimidic acid

(2e)-2-methyl-3-[4-(4-methylidenecyclohexyl)furan-2-yl]prop-2-enimidic acid

C15H19NO2 (245.1416)


   

n-[2-(4-methoxyphenyl)ethenyl]-n,3-dimethylbut-2-enamide

n-[2-(4-methoxyphenyl)ethenyl]-n,3-dimethylbut-2-enamide

C15H19NO2 (245.1416)


   

(2r)-2-hydroxy-1-(1h-indol-3-yl)-5-methylhexan-3-one

(2r)-2-hydroxy-1-(1h-indol-3-yl)-5-methylhexan-3-one

C15H19NO2 (245.1416)


   

2-hydroxy-1-(1h-indol-3-yl)-5-methylhexan-3-one

2-hydroxy-1-(1h-indol-3-yl)-5-methylhexan-3-one

C15H19NO2 (245.1416)


   

[(2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxyethylidene)amino]acetic acid

[(2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxyethylidene)amino]acetic acid

C10H19N3O4 (245.1375)


   

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid

(2s)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid

C10H19N3O4 (245.1375)


   

5-hydroxy-5,7,7-trimethyl-5ah,6h,8h,8ah-cyclopenta[g]isoquinolin-9-one

5-hydroxy-5,7,7-trimethyl-5ah,6h,8h,8ah-cyclopenta[g]isoquinolin-9-one

C15H19NO2 (245.1416)


   

n-[(1z)-2-(4-methoxyphenyl)ethenyl]-n,3-dimethylbut-2-enamide

n-[(1z)-2-(4-methoxyphenyl)ethenyl]-n,3-dimethylbut-2-enamide

C15H19NO2 (245.1416)


   

2-methyl-3-[4-(4-methylidenecyclohexyl)furan-2-yl]prop-2-enimidic acid

2-methyl-3-[4-(4-methylidenecyclohexyl)furan-2-yl]prop-2-enimidic acid

C15H19NO2 (245.1416)


   

8-isopropyl-1,5-dimethylimidazo[2,1-b]purin-4-one

8-isopropyl-1,5-dimethylimidazo[2,1-b]purin-4-one

C12H15N5O (245.1277)